Regeneron to Acquire 23andMe for $256M
Regeneron Pharmaceuticals has agreed to acquire 23andMe’s consumer genetics business and assets for $256 million, following 23andMe’s Chapter 11 bankruptcy.
More Videos
How Babylist Is Changing the Way You Get Ready for That Newest Family Member
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
From Viral Moments to Vital Conversations: Rachel Lindsay & Van Lathan On 'Higher Learning'
Celebrating 5 years of the hit podcast 'Higher Learning' with hosts Rachel Lindsay and Van Lathan on the floor of the New York Stock Exchange. Watch!
Returns, Reimagined: How ReturnPro Uses Smart Tech to Simplify Send-Backs
ReturnPro CEO Sender Shamiss to discuss how his company is changing the way we make returns and how Trump's tariffs are affecting the return business. Watch!
U.S.–China Trade Truce: What It Means and What Comes Next
Chris Beauchamp, Chief Market Analyst at IG International, joins J.D. Durkin to give analysis on the recent trade truce between the U.S. and China. Watch!
From Swindled to CEO: How Tinder Swindler Star Launched an ID Verification Startup
Pernilla Sjöholm, star of the Tinder Swindler on Netflix and founder of IDfier, explains how she went from fraud to co-founder of her own company. Watch!
Go Inside Coinbase's $2.9B Deribit Acquisition: A Strategic Move as It Joins the S&P 500
Shan Aggarwal, VP of Corporate and Business Development at Coinbase, discusses the company's acquisitio of Deribit as it heads into the S&P 500. Watch!
